DEA Places Synthetic Opiate Into Schedule II
The Drug Enforcement Administration placed the synthetic opiate thiafentanil into Schedule II of the Controlled Substances Act, in a final rule (here). Effective Aug. 26, thiafentanil is subject to new registration, labeling, recordkeeping, and import and export requirements. DEA is accepting comments on the rule until Sept. 26.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
(Federal Register 08/26/16)